<DOC>
	<DOCNO>NCT01945424</DOCNO>
	<brief_summary>The Sanofi Pasteur Quadrivalent Influenza Vaccine ( QIV ) Pregnancy Registry prospectively recruit pregnancy surveillance program design collect analyze information vaccine exposure , pregnancy outcome , fetal offspring outcome .</brief_summary>
	<brief_title>Sanofi Pasteur Quadrivalent Influenza Vaccine ( QIV ) Pregnancy Registry</brief_title>
	<detailed_description>Pregnant woman enrol registry prospectively ( exposure QIV routine clinical setting knowledge pregnancy outcome ) . Women expose QIV without adverse event record Global Pharmacovigilance Database medically review . Pregnancy outcomes seek via questionnaire send reporter enrollment , estimate time delivery , six month delivery . Descriptive statistical method primary approach summarize data . No vaccine product provide administered part registry protocol .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Pregnant woman enrol registry prospectively ( exposure Quadrivalent Influenza Vaccine ( QIV ) conduct prenatal test could provide knowledge outcome pregnancy ) . If condition fetus already assess prenatal testing ( e.g. , targeted ultrasound , amniocentesis , etc . ) , report consider retrospective report . Retrospective report also eligible registry analyze separately prospective report .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Quadrivalent Influenza Vaccine</keyword>
	<keyword>Pregnancy Registry</keyword>
	<keyword>Influenza</keyword>
</DOC>